Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

EvidenceVariable: OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years

Official URL: https://fevir.net/resources/EvidenceVariable/32143 Version: 1.0.0-ballot3
Standards status: Informative Active as of 2022-05-28 Computable Name: OutcomeVariable_American_Diabetes_Association_composite_triple_end_point_for_metabolic_control_at_5_years
Other Identifiers: FEvIR Object Identifier: FEvIR Object Identifier#32143, OID:2.16.840.1.113883.4.642.40.44.24.81

Copyright/Legal: https://creativecommons.org/licenses/by-nc-sa/4.0/

The American Diabetes Association composite triple end point of hemoglobin A1c less than 7.0%, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg at 5 years

version: 13; Last updated: 2023-12-06 21:24:16+0000

Profile: VariableDefinition

ArtifactPublicationStatus: Active

url: EvidenceVariable OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years

identifier: FEvIR Object Identifier/32143, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.24.81

version: 1.0.0-ballot3

name: OutcomeVariable_American_Diabetes_Association_composite_triple_end_point_for_metabolic_control_at_5_years

title: OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years

status: Active

date: 2022-05-28 12:16:43+0000

author: Brian S. Alper:

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

description:

The American Diabetes Association composite triple end point of hemoglobin A1c less than 7.0%, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg at 5 years

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

actual: true

handling: dichotomous variable